
J&J begins crucial battle over $10 billion baby powder settlement
By Dietrich Knauth NEW YORK (Reuters) - Johnson & Johnson (NYSE:JNJ) faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on its third attempt to resolve thousands of lawsuits through a subsidiary's bankruptcy. U.S. Bankruptcy Judge Christopher Lopez in Houston will dec ...